Anzeige
Mehr »
Donnerstag, 03.07.2025 - Börsentäglich über 12.000 News
+210 % Kursgewinn Year to Date: Neuausrichtung nimmt Fahrt auf - jetzt exklusives CEO-Interview ansehen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
311 Leser
Artikel bewerten:
(1)

Metwood, Inc.: Emerge Nutraceuticals a Wholly Owned Subsidiary of Metwood Inc., Signs MOU to Acquire Cholesterade

MOUNT DORA, FL / ACCESSWIRE / July 18, 2022 / Today, Metwood (OTC PINK:MTWD), Emerge Nutraceuticals, has announced that they have entered into a MOU to acquire Cholesterade®, from Go Epic Health, Inc., a wholly owned subsidiary of LEON ( LEON ) for an undisclosed number of shares and is expected to close sometime within the 3 rd quarter.

Cholesterade ® is a natural, acai-fiber-based powder supplement containing 7 grams of fiber per

serving and easily soluble in water. It comes in three flavors: Mixed Berry, Orange and Lemon Lime. Clinically proven to reduce cholesterol over 8 weeks. The creator of this revolutionary product is none other than Dr. J. Robert Cade. Dr. J. Robert Cade was an American physician, university professor, research scientist and inventor. He is most widely remembered as the leader of the research team that formulated the sports drink Gatorade®. www.Cholesterade.com

Emerge Nutraceuticals (MTWD) is a nutraceutical manufacturer selling proprietary soft gels, powders, and liquid formulations for vitamins, proteins and the body-building industry. The company has their own branded products in addition to wholesale white label manufacturing. The mission is to deliver organic, healthy solutions and natural alternatives to individuals seeking non-prescription remedies to better their health. www.emergenutraceuticals.com

About Emerge Nutraceuticals

Emerge Nutraceuticals is a nutraceutical manufacturer selling proprietary soft gels, powders, and liquid formulations for vitamins, proteins and the body-building industry. The company has their own branded products in addition to wholesale and white label manufacturing.

About Cholesterade

Cholesterade® was created by the late Dr. Robert Cade, the creator of Gatorade®. Cholesterade provides a natural, delicious and economical solution to help meet NIH requirements for therapeutic lifestyles changes using non-drug intervention to lower cholesterol prior to consideration of statin intervention.

Forward-Looking Statements Disclosure:

This press release may contain "forward-looking statements" within the meaning of the federal securities laws. In this context, forward-looking statements may address the Company's expected future business and financial performance, and often contain words such as "anticipates," "beliefs," "estimates," "expects," "intends," " plans," "seeks," "will," and other terms with similar meaning. These forward-looking statements by their nature address matter that are, to different degrees, uncertain. Although the Company believes that the assumptions upon which its forward-looking statements based are reasonable, it can provide no assurances that these assumptions will prove to be correct. All forward-looking statements in this press release are expressly qualified by such cautionary statements, risk, and uncertainties, and by reference to the underlying assumptions.

Contact:

Keith Thomas, CEO
Metwood Inc
IR@emergenutra.com

James Price
Chairman/CEOat Go Epic Health Inc
P: (858) 525-5695
E: JamesPrice@LeoneAsset.com

SOURCE: Metwood, Inc.



View source version on accesswire.com:
https://www.accesswire.com/708908/Emerge-Nutraceuticals-a-Wholly-Owned-Subsidiary-of-Metwood-Inc-Signs-MOU-to-Acquire-Cholesterade

© 2022 ACCESS Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.